Indonesia's Private Health Sector Market in the JKN Era

The U.S. Agency for International Development (USAID)-funded Health Policy Plus (HP+) project and Indonesia's National Team for the Acceleration of Poverty Reduction (TNP2K) conducted analysis to explore these questions, focusing on JKN's impact on pharmaceutical and medical device companies and private hospitals. We reviewed whether new actors have joined the market following JKN implementation—especially in geographical areas that were not well-served previously—whether the private sector's products or services have diversified, and whether JKN has motivated healthy competition between companies and hospitals. This resource is also translated in Indonesian and the translated resource can be found through the document link.